# Effect of Dapagliflozin on Blood Pressure Variability in Prediabetes and Prehypertension

> **NCT03006471** · PHASE4 · COMPLETED · sponsor: **University of Guadalajara** · enrollment: 30 (actual)

## Conditions studied

- PreDiabetes
- Prehypertension

## Interventions

- **DRUG:** Dapagliflozin
- **DRUG:** Placebo - Cap

## Key facts

- **NCT ID:** NCT03006471
- **Lead sponsor:** University of Guadalajara
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-30
- **Primary completion:** 2018-03-30
- **Final completion:** 2018-06-29
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03006471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03006471, "Effect of Dapagliflozin on Blood Pressure Variability in Prediabetes and Prehypertension". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03006471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*